| human | Q5 |
| P2798 | Loop ID | 607050 |
| P496 | ORCID iD | 0000-0002-3875-3513 |
| 0000-0002-6279-7866 | ||
| P1153 | Scopus author ID | 36062217100 |
| P108 | employer | New York University School of Medicine | Q3100195 |
| Weill Cornell Medicine | Q3567094 | ||
| NYU Langone Medical Center | Q6956114 | ||
| P106 | occupation | researcher | Q1650915 |
| Q35231622 | Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly |
| Q36110188 | Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents |
| Q37219729 | An entorhinal cortex sulcal pattern is associated with Alzheimer's disease |
| Q51766109 | Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease. |
| Q37237593 | Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly |
| Q37623183 | Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. |
| Q112584990 | Cardiovascular disease and cumulative incidence of cognitive impairment in the Health and Retirement Study |
| Q38902474 | Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET. |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q34269817 | Comparison of human septal nuclei MRI measurements using automated segmentation and a new manual protocol based on histology |
| Q36298335 | Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease |
| Q33590723 | Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies |
| Q90668988 | Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension |
| Q37701671 | Early detection of Alzheimer's disease with PET imaging. |
| Q31047773 | Effects of unmeasured heterogeneity in the linear transformation model for censored data. |
| Q36933792 | Effects of vascular risk factors, statins, and antihypertensive drugs on PiB deposition in cognitively normal subjects |
| Q38829041 | Evaluation of Early Dementia (Mild Cognitive Impairment). |
| Q34730215 | FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease |
| Q37415324 | FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease |
| Q89766455 | Fluoride exposure alters Ca2+ signaling and mitochondrial function in enamel cells |
| Q34627635 | Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia |
| Q46952456 | Gender differences in brain reserve : an (18)F-FDG PET study in Alzheimer's disease. |
| Q36412536 | Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease |
| Q36725261 | Hippocampal hypometabolism predicts cognitive decline from normal aging |
| Q48380741 | Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. |
| Q92640199 | Image processing and analysis methods for the Adolescent Brain Cognitive Development Study |
| Q31108280 | Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. |
| Q33778436 | Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's |
| Q91836449 | Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology |
| Q35161146 | Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease |
| Q34193658 | Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease. |
| Q91960766 | Neck management in patients with olfactory neuroblastoma |
| Q33834876 | Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study |
| Q35222298 | Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals |
| Q35231675 | Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders |
| Q34955852 | Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study |
| Q92111879 | Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease |
| Q92420317 | Precisely-Measured Hydration Status Correlates with Hippocampal Volume in Healthy Older Adults |
| Q90000439 | Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma |
| Q48218480 | Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer's disease |
| Q59844929 | Quantitative evaluation of tau PET tracers F-THK5351 and F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization |
| Q34066828 | Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matter |
| Q35557099 | Reduced retention of Pittsburgh compound B in white matter lesions |
| Q37219754 | Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease |
| Q50036585 | Reply: Cerebrospinal Fluid, Hyposmia and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis |
| Q42054888 | Resting-state glucose metabolism level is associated with the regional pattern of amyloid pathology in Alzheimer's disease |
| Q35046339 | Structural brain changes in normal individuals with a maternal history of Alzheimer's |
| Q90132271 | TRPM7 activation potentiates SOCE in enamel cells but requires ORAI |
| Q50133231 | The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease |
| Q31030916 | The role of quantitative structural imaging in the early diagnosis of Alzheimer's disease |
| Q48664610 | The use of frailty hazard models for unrecognized heterogeneity that interacts with treatment: considerations of efficiency and power. |
| Q42327985 | Transient and chronic seizure-induced inflammation in human focal epilepsy |
| Q46823529 | Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. |
Search more.